Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
Go back to Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer| (NASDAQ: STOK) | Delayed: 32.97 +0.01 (0.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.96 | 52 Week High | $ | |||
| Open | $32.94 | 52 Week Low | $ | |||
| Day High | $33.56 | P/E | N/A | |||
| Day Low | $32.05 | EPS | $ | |||
| Volume | 977,943 | |||||

